Cresilon, Inc. Stock
Cresilon is a medical device company that produces and markets solutions for trauma care.
Sign up today and learn more about Cresilon, Inc. Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cresilon, Inc. Stock
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL(TM), is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.
Funding History
| May 2013 | $0 |
|---|---|
| May 2015 | $0 |
| January 2016 | $0 |
| December 2017 | $0 |
Management
CFO, Co-Founder
Isaac Miller
CEO, Co-Founder
Joe Landolina
Press
patents - Apr, 14 2024
In-situ cross-linkable polymeric compositions and methods thereofpatents - Apr, 14 2024
Highly efficacious hemostatic adhesive polymer scaffoldpatents - Apr, 14 2024
Delivery device for hemostatic compositionsprnewswire - Apr, 7 2024
Cresilon Launches "VETIGEL Gives" to Sponsor Life-Saving Surgeries for Animals in Neednewyorkyimby - Jan, 30 2024
Aanika Biosciences And Cultured Colonies Sign Lease At ...EquityZen Recognized As:
